Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has informed NSE about the schedule of a meeting, which typically refers to an upcoming investor or analyst interaction. No specific date, agenda, or participants were disclosed in this filing. Such disclosures are routine and made under SEBI listing regulations to keep investors informed of management interactions. The full details of date, time, and venue are expected to follow in a subsequent intimation.
This is a routine procedural disclosure and is unlikely to move the stock price on its own. Investors should watch for the detailed intimation to learn about the agenda, as investor meetings sometimes precede earnings, guidance updates, or corporate developments.